• 01 Aug 25
 

Irish Takeover Panel - Disclosure Table



RNS Number : 6543T
Irish Takeover Panel
01 August 2025
 

IRISH TAKEOVER PANEL                                            
Disclosure Table                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

The following companies are deemed to be in an offer period for the purposes of disclosure under the Rules of the Irish Takeover Panel:

_______________________________________________________________

Offeree:          Dalata Hotel Group plc

Offer period commenced:  6 March 2025

€0.01 ordinary shares; ISIN: IE00BJMZDW83; NSI: 211,483,988

Offeror:          Pandox Ireland Tuck Limited, a company wholly owned by Pandox AB and Eiendomsspar AS

Disclosure of dealings and positions in this offeror is not required

Offeror identified: 3 June 2025

Rule 2.6(a) deadline: N/A

 

Offeree:          Mural Oncology plc

Offer period commenced:  15 April 2025

$0.01 ordinary shares; ISIN: IE000LK2BOB4; NSI: 17,268,881

Offeror:          N/A

Offeror identified: N/A

Rule 2.6(a) deadline: N/A

 

 

Irish Takeover Panel                                       1 August 2025

Lower Ground Floor

76 Merrion Square

Dublin D02 X4T1

 

Telephone:    + 353-1-678 9020                            

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEDZGGRGMGGKZM